Effects of Betalains on Cardiovascular Health and Quality of Life

Last updated: November 13, 2025
Sponsor: King's College London
Overall Status: Completed

Phase

N/A

Condition

Aneurysm

Low Blood Pressure (Hypotension)

Treatment

Placebo

Betalains

Clinical Study ID

NCT06117007
HeartBeet Study
  • Ages 40-65
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this randomized, double-blind, placebo-controlled, cross-over trial is to investigate the effects of beetroot-derived betalains on cardiovascular health, sleep and quality of life in healthy middle-aged individuals. The main question[s] it aims to answer are:

  • Do betalains improve vascular function?

  • Do betalains improve sleep?

  • Do betalains improve quality of life?

Participants will be involved with the following:

  • Consuming a daily betalain-rich or placebo capsule for a month

  • Non-invasive cardiovascular measurements

  • Wearing a fitness tracker for tracking physical activity and sleep

  • Answering questionnaires regarding quality of life

Researchers will compare results between the intervention versus the placebo group to see if any of the study outcomes are significantly different.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Aged between 40 and 65 years

  • BMI between 25-29.9 kg/m2

  • Own a smartphone.

  • Able to understand the nature of the study and give informed consent

  • Have not gained or lost more than 10% of body weight (within the past 3 months)

  • Not currently involved or have participated in another biomedical study (within thelast 3 months)

Exclusion

Exclusion Criteria:

  • Smoking or vaping (within the last 2 years)

  • Vegetarian or vegan (due to capsule material)

  • Medical history of chronic disease [coronary artery disease, previous myocardialinfarction (heart attack), stroke, peripheral artery disease, diabetes mellitus,chronic kidney disease, metabolic syndrome, malignancies, etc]

  • Grade II hypertension (blood pressure: >160/100 mmHg)

  • Under medication that can affect the cardiovascular system (within the last 2months)

  • Taking supplements (except vitamin D and iron) (within the last month)

  • Intolerances or allergies toward beetroots, dragon fruit or rice hulls

  • History of excess alcohol intake or substance abuse.

  • Pregnant or planning to become pregnant in the next 6 months

  • Under hormonal replacement therapy (contraceptives are allowed)

Study Design

Total Participants: 42
Treatment Group(s): 2
Primary Treatment: Placebo
Phase:
Study Start date:
October 30, 2023
Estimated Completion Date:
December 19, 2024

Connect with a study center

  • Metabolic Research Unit (King's College London)

    London 2643743, London SE1 9NH
    United Kingdom

    Site Not Available

  • Metabolic Research Unit (King's College London)

    London, SE1 9NH
    United Kingdom

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.